Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

People

Robert P. Ryall

by Linda Wang
May 8, 2017 | A version of this story appeared in Volume 95, Issue 19

Robert P. Ryall
[+]Enlarge
Credit: Courtesy of Sanofi Pasteur
Photo of Robert P. Ryall.
Credit: Courtesy of Sanofi Pasteur

Robert P. Ryall, 59, died on Nov. 25, 2016, in East Stroudsburg, Pa.

“Resolute, passionate, and self-effacing are a few words that best describe the essence of Bob Ryall. These traits served him well in his pioneering work with a polysaccharide-protein conjugates vaccine, resulting in Menactra for meningococcal meningitis, a top-selling vaccine for Sanofi Pasteur. He was indifferent to the vanities of the corporate world, and so Bob flourished for 27 years in the small-company atmosphere of Connaught Laboratories-turned-Sanofi Pasteur. His private life reflected his professional life, always driven to excel at whatever he was doing. He cherished the company of colleagues, friends, and family, and all were richer for having known him.”—Ralph R. Ryall, brother

Most recent title: senior director, Sanofi Pasteur

Education: B.S., chemistry, Le Moyne College, 1979; Ph.D., organic chemistry, Pennsylvania State University, 1987

Survivors: sister, Beverly; brother, Ralph

To recognize your late loved one or colleague, submit obituary information at cenm.ag/obits.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.